Legal & General Group PLC Galera Therapeutics, Inc. Transaction History

Legal & General Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$6.08 - $10.44 $5,982 - $10,272	-984 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$8.35 - $12.39 $601 - $892	-72 Reduced 6.82%	984 $9,000
Q3 2020 Nov 13, 2020	SELL	$6.96 - $9.12 $2,540 - $3,328	-365 Reduced 25.69%	1,056 $10,000
Q2 2020 Aug 14, 2020	BUY	$7.14 - $14.41 $9,589 - $19,352	1,343 Added 1721.79%	1,421 $10,000
Q1 2020 May 14, 2020	BUY	$5.89 - $17.67 $459 - $1,378	78 New	78 $1,000

10.7M

10.3K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $3.76M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.